Clinical trials / New Mexico
Psychedelic and ketamine trials recruiting in New Mexico
3 trials registered on ClinicalTrials.gov were recruiting at one or more sites in New Mexico on 26 Oct 2026. By substance: Psilocybin 2, MDMA 1. By condition: ptsd 2, opioid use disorder 2.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Phase 2PsilocybinNCT06796062
Psilocybin for Opioid Use Disorder (OUD)
- Conditions:
- Opioid Use Disorder
- Sponsor:
- NYU Langone Health
- Who:
- ages 18 Years to 65 Years, 480 participants planned
- Duke City Recovery Toolbox, Albuquerque, New Mexico
- University of New Mexico, Albuquerque, New Mexico
Phase 2MDMANCT05219175
MDMA for Co-occurring PTSD and OUD After Childbirth
- Conditions:
- Stress Disorders, Post-Traumatic; Opioid Use Disorder
- Sponsor:
- University of New Mexico
- Who:
- ages 18 Years and over, 15 participants planned
- University of New Mexico Health Sciences, Albuquerque, New Mexico
Phase 1PsilocybinNCT07506395
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder (GPAT)
- Conditions:
- PTSD
- Sponsor:
- University of New Mexico
- Who:
- ages 18 Years to 89 Years, 36 participants planned
- Interdisciplinary Substance Use and Brain Injury (ISUBI), Albuquerque, New Mexico